Ng George K (CIK 1638744) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy PCSA (3,057 shares), Buy PCSA (2,465 shares), Buy PCSA (2,129 shares), Buy PCSA (1,843 shares), Buy PCSA (1,843 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 3,057 | $5,900 |
| 2026-06-16 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 2,465 | $5,472 |
| 2026-06-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 2,129 | $5,472 |
| 2026-05-19 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 1,843 | $5,474 |
| 2026-05-19 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 1,843 | $5,474 |
| 2026-05-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 2,034 | $5,471 |
| 2026-04-30 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 2,136 | $5,415 |
| 2026-04-30 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 1,843 | $5,474 |
| 2026-04-17 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 1,843 | $5,474 |
| 2025-01-29 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | Buy | 87,200 | $0 |
Source: SEC Form 4 filings · as of 2026-07-01